VSIG4 and lymphoma: Recently, elevated levels of circulating VSIG4 have been proposed as a surrogate marker for lymphoma‐associated hemophagocytic lymphohistiocytosis, a syndrome of severe inflammation resulting from the expansion of activated Mφ and lymphocytes that are defective in cytotoxic functions (Yuan et al., 2020).